CG0070 for the treatment of non-muscle invasive bladder cancer (NMIBC) unresponsive to Bacillus Calmette-Guerin (BCG)

被引：0

作者：

Uchio, Edward M. ^{[1
]}

Li, Roger ^{[2
]}

Steinberg, Gary ^{[3
]}

Lamm, Donald ^{[4
]}

Kamat, Ashish ^{[5
]}

Packiam, Vignesh ^{[6
]}

Anderson, Paul ^{[7
]}

Ku, Ja Hyeon ^{[8
]}

Chisamore, Michael ^{[9
]}

McAdory, John ^{[10
]}

Hnat, Nataliya ^{[10
]}

Kim, Jee-Hyun ^{[10
]}

Grandi, Paola ^{[10
]}

Burke, James ^{[10
]}

机构：

[1] UCI, Irvine, CA USA

[2] Moffit Canc Ctr, Tampa, FL USA

[3] NYU Langone Hlth, New York, NY USA

[4] BCG Oncol, Phoenix, AZ USA

[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[6] Univ Iowa Hlth Care, Iowa City, IA USA

[7] Royal Melbourne Hosp, Melbourne, Australia

[8] Seoul Natl Univ Hosp, Seoul, South Korea

[9] Merck, Rahway, NJ USA

[10] UCI, CaliforniaCG Oncol, Irvine, CA USA

来源：

CANCER SCIENCE | 2023年 / 114卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

S21-4

引用

页码：1587 / 1587

页数：1

共 50 条

[31] Bacillus Calmette-Guerin (BCG) and alternatives Drug treatment of high-risk non-muscle invasive bladder cancer
Leucht, K.
Foller, S.
Grimm, Marc-Oliver
UROLOGE, 2021, 60 (11): : 1400 - 1408
[32] RE-EVALUATION OF INTRAVESICAL GEMCITABINE IN BACILLUS CALMETTE-GUERIN UNRESPONSIVE NON-MUSCLE INVASIVE BLADDER CANCER
Escano, Manuel R. De Jesus
Vertosick, Emily
Benfante, Nicole
Lenis, Andrew T.
Reisz, Peter A.
Goh, Alvin
Cha, Eugene
Donahue, Timothy F.
Bochner, Bernard H.
Sjoberg, Dan
Pietzak, Eugene J.
JOURNAL OF UROLOGY, 2021, 206 : E299 - E299
[33] Emerging treatment options for bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
Kokorovic, Andrea
Ory, Jesse
Saad, Fred
CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2022, 16 (01) : 48 - 53
[34] Bacillus Calmette-Guerin for the Treatment of Non-muscle Invasive Bladder Cancer: History and Current Status
Liu, Gang
Li, Bingheng
Xu, Ziyang
Wang, Jie
Ma, Sai
Kan, Yi
Mao, Lijun
DISCOVERY MEDICINE, 2022, 33 (169) : 85 - 92
[35] Predictive biomarkers of response to bacillus Calmette-Guerin immunotherapy and bacillus Calmette-Guerin failure for non-muscle invasive bladder cancer
Wang, Ziting
So, Wei Zheng
Loh, Kep Yong
Lim, Yew Koon
Mahendran, Ratha
Wu, Qing Hui
Chiong, Edmund
INTERNATIONAL JOURNAL OF UROLOGY, 2022, 29 (08) : 807 - 815
[36] Pembrolizumab for high-risk (HR) non-muscle invasive bladder cancer (NMIBC) unresponsive to bacillus Calmette-Guerin (BCG): Phase II KEYNOTE-057 trial
de Wit, R.
Kulkarni, G. S.
Uchio, E.
Singer, E. A.
Krieger, L.
Grivas, P.
Bajorin, D.
Seo, H. K.
Mourey, L.
Kamat, A.
Nishiyama, H.
Kapadia, E.
Nam, K.
Frenkl, T.
Balar, A.
ANNALS OF ONCOLOGY, 2018, 29 : 304 - 304
[37] The Effectiveness of Bacillus Calmette-Guerin (BCG) Maintenance Treatment in Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Kim, B.
Ha, J.
Park, C.
Kim, C.
UROLOGY, 2012, 80 (03) : S215 - S216
[38] Smoke load prognostic impact on bacillus Calmette-Guerin (BCG) treated non-muscle invasive bladder cancer
Andrade, Danilo Leite
Moretti, Tomas Bernardo Costa
Neto, Wilmar Azal
Benedetti, Julia
Reis, Leonardo Oliveira
INTERNATIONAL UROLOGY AND NEPHROLOGY, 2020, 52 (08) : 1471 - 1476
[39] Role of immunotherapy in bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer
Mukherjee, Neelam
Svatek, Robert S.
Mansour, Ahmed M.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2018, 36 (03) : 103 - 108
[40] CARCINOGENESIS AND BACILLUS CALMETTE-GUERIN (BCG) INTRAVESICAL TREATMENT OF NON-MUSCLE INVASIVE BLADDER CANCER UNDER TRYPTOPHAN AND THYMINE SUPPLEMENTATION
Ossick, Marina
Kiehl, Isis
Salustiano, Ana Clara
Ferrari, Karen
Degasperi, Giovanna
Linarelli, Maria
Reis, Leonardo
JOURNAL OF UROLOGY, 2021, 206 : E1133 - E1133

← 1 2 3 4 5 →